Articles by tag: biologics

Benralizumab for eosinophilic esophagitis: EMA approval 2026

Analysis of EMA approval of benralizumab for the treatment of eosinophilic esophagitis: phase 3 MESSINA data, comparison with dupilumab, risks and prospects. Read.

Fasenra and HES: what FDA approval in 2026 means

FDA approved Fasenra for the treatment of hypereosinophilic syndrome. How benralizumab is better than analogues, and why this is a strategy shift for AstraZeneca. Learn the prospects.

Saphnelo Pen approved by FDA: treating lupus at home

FDA approved Saphnelo subcutaneous pre-filled pens for lupus treatment. Patients can self-administer the drug without visiting a clinic. Learn about the breakthrough in therapy.